Arrhythmia Clinical Trial
Official title:
Randomized Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry Monitoring
This is a randomized trial of a best-practice alert delivered via the electronic medical record (Apex) to physicians on the Medicine service at UCSF Medical Center over a six month period. The alert notifies physicians that their order for continuous cardiac monitoring (telemetry) for a given patient has exceeded the duration recommended by national guidelines and offers them the opportunity to discontinue monitoring if they feel it is clinically appropriate. Physicians will be randomized to either receive the BPA or not, with the anticipation that physicians in the intervention arm will discontinue unnecessary telemetry.
Physicians often order continuous cardiac monitoring (telemetry) for their patients in the
hospital. Telemetry provides real-time heart rate and rhythm monitoring and can be useful for
detecting arrhythmias and evaluating the response to cardiac therapies. Leads on the
patient's chest detect the electrical signature of the heartbeat, relay the information to a
box in the patient's shirt pocket, and this box relays the signal in real-time to a control
room where technicians monitor for abnormalities. If a technician notes an abnormality he or
she will contact the appropriate provider. Currently, physicians can order telemetry at UCSF
Medical Center with or without providing an indication for its use. In addition, telemetry
remains active until the provider discontinues it or the patient leaves the hospital. Studies
at UCSF and hospitals nationwide demonstrate that telemetry is overused. Physicians either
order it without a valid indication or they do not remember to discontinue it when the
indication is no longer valid. Guidelines published by the American Heart Association provide
clarity regarding what clinical conditions warrant telemetry and for how long. However,
numerous studies demonstrate that physicians do not faithfully follow these guidelines. This
led the American Board of Internal Medicine Foundation to urge physicians in Hospital
Medicine to develop protocols governing the use of telemetry outside of the intensive care
unit in a 2013 campaign called Choosing Wisely.
The harms of telemetry overuse are myriad: 1) Frequent false or unimportant alarms lead to
alarm fatigue and studies have documented patient harm when subsequent real alarms were
ignored. False alarms also often necessitate a visit to the patient by the nurse and this
distracts the nurse from other patients, 2) Monitoring patients without an active cardiac
condition often reveals clinically unimportant abnormalities that obligate physicians to work
them up, just by virtue of having seen them on monitor. The work-up then results in
unnecessary cost and anxiety, 3) Leads on the patient's chest often fall off with movement
and have to be replaced by the nurse. This discourages patients from getting more exercise
while they are hospitalized, which is a risk factor for muscle atrophy, and getting enough
sleep, which is a risk factor for delirium, 4) Telemetry is not available for all hospital
beds at UCSF and even units where it is available have limitations for the types of
arrhythmias they can monitor. Thus, telemetry monitoring for a patient who does not need it
can prevent another patient from having timely access to a monitor-capable bed.
In order to reduce unnecessary telemetry use, we propose to use a best-practice alert (BPA)
delivered to physicians by the electronic medical record (Apex). We propose to study this BPA
in a randomized trial. Physicians on the Medicine service would be randomized to either
receive the BPA on their patients or not during a six month study period. We would examine
both groups for the following outcomes: physician response to the alert, total hours of
telemetry used, number of rapid response activations for arrhythmic events, and number of
code blue events.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05048602 -
Drug-induced Brugada Syndrome Research Database
|
||
Completed |
NCT05053243 -
Clinical Validation of the AliveCor Kardia 12L and 6L Devices
|
N/A | |
Completed |
NCT01913561 -
The Use of Master Caution Garment for Continuous Monitoring for Arrhythmia Detection
|
N/A | |
Completed |
NCT01688648 -
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT01396226 -
A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients
|
Phase 2 | |
Terminated |
NCT00721149 -
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use Study
|
Phase 3 | |
Completed |
NCT00756886 -
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
|
N/A | |
Terminated |
NCT00624520 -
Mental Stress Reduction in Defibrillator Patients
|
Phase 3 | |
Completed |
NCT00510029 -
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously
|
Phase 1 | |
Completed |
NCT00578617 -
Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial
|
N/A | |
Active, not recruiting |
NCT00135174 -
Cost-Effectiveness of Routine Follow-up Visits in Patients With a Pacemaker: The Followpace Study
|
N/A | |
Completed |
NCT00119847 -
Electrophysiological Effects of Late PCI After MI
|
N/A | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Completed |
NCT00035490 -
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
|
Phase 3 | |
Completed |
NCT00004560 -
Public Access Defibrillation (PAD) Community Trial
|
Phase 3 | |
Completed |
NCT01076361 -
Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study
|
N/A | |
Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
Completed |
NCT01076348 -
Model 4965 Post-Approval Study
|
||
Completed |
NCT00622453 -
Arrhythmias in Myotonic Muscular Dystrophy
|
N/A | |
Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 |